Yıl: 2017 Cilt: 32 Sayı: 1 Sayfa Aralığı: 67 - 70 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

A Rare Adverse Effect of Anti-Tumor Necrosis Factor Alpha Therapy: Sarcoidosis

Öz:
Anti-tumor necrosis factor alpha (anti-TNF-a) therapy has been widely used for the management of rheumatologic diseases. The most frequent adverse effects of anti-TNF-a therapy are infections and malignancies while sarcoidosis is a rare condition. On the other hand, anti-TNF-a therapy has been used in the treatment of sarcoidosis. Elucidation of this paradoxical issue is unclear. In this article, we report an ankylosing spondylitis patient who was diagnosed as sarcoidosis during the period of etanercept usage. Sarcoidosis as a possible adverse effect should be kept in mind during anti-TNF-a therapy.
Anahtar Kelime:

Konular: Romatoloji
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Papamichael K, Mantzaris GJ, Peyrin-Biroulet L. A safety assessment of anti-tumor necrosis factor alpha therapy for treatment of Crohn's disease. Expert Opin Drug Saf 2016;15:493-501.
  • 2. Sampaio-Barros PD, van der Horst-Bruinsma IE2. Adverse effects of TNF inhibitors in SpA: are they different from RA? Best Pract Res Clin Rheumatol 2014;28:747-63.
  • 3. Thongpooswan S, Abrudescu A. Lung sarcoidosis in etanercept treated rheumatoid arthritis patient: a case report and review of the literature. Case Rep Rheumatol 2014;2014:358567.
  • 4. Daïen CI, Monnier A, Claudepierre P, Constantin A, Eschard JP, Houvenagel E, et al. Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases. Rheumatology (Oxford) 2009;48:883-6.
  • 5. Gifre L, Ruiz-Esquide V, Xaubet A, Gómez-Puerta JA, Hernández MV, Sanmartí R. Lung sarcoidosis induced by TNF antagonists in rheumatoid arthritis: a case presentation and a literature review. Arch Bronconeumol 2011;47:208-12.
  • 6. Wendling D, Prati C. Paradoxical effects of anti-TNF-a agents in inflammatory diseases. Expert Rev Clin Immunol 2014;10:159-69.
  • 7. Antoniu SA. Targeting the TNF-alpha pathway in sarcoidosis. Expert Opin Ther Targets 2010;14:21- 9.
  • 8. Utz JP, Limper AH, Kalra S, Specks U, Scott JP, VukPavlovic Z, et al. Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis. Chest 2003;124:177-85.
  • 9. González-López MA, Blanco R, González-Vela MC, Fernández-Llaca H, Rodríguez-Valverde V. Development of sarcoidosis during etanercept therapy. Arthritis Rheum 2006;55:817-20.
  • 10. Unterstell N, Bressan AL, Serpa LA, Fonseca e Castro PP, Gripp AC. Systemic sarcoidosis induced by etanercept: first Brazilian case report. An Bras Dermatol 2013;88:197-9.
  • 11. Akiyama M, Kaneko Y, Hanaoka H, Kuwana M, Takeuchi T. Acute kidney injury due to renal sarcoidosis during etanercept therapy: a case report and literature review. Intern Med 2015;54:1131-4.
  • 12. Ishiguro T, Takayanagi N, Kurashima K, Matsushita A, Harasawa K, Yoneda K, et al. Development of sarcoidosis during etanercept therapy. Intern Med 2008;47:1021-5.
  • 13. Available from: https://www.uptodate.com/contents/ overview-of-biologic-agents-in-the-rheumatic-disease s?source=machineLearning&search=etanercept&sel ectedTitle=6%7E150&sectionRank=1&anchor=H13 #H13, [Access: June 28, 2016]
APA MENGİ G, GÖĞÜŞ F (2017). A Rare Adverse Effect of Anti-Tumor Necrosis Factor Alpha Therapy: Sarcoidosis. , 67 - 70.
Chicago MENGİ Gönen,GÖĞÜŞ FERİDE NUR A Rare Adverse Effect of Anti-Tumor Necrosis Factor Alpha Therapy: Sarcoidosis. (2017): 67 - 70.
MLA MENGİ Gönen,GÖĞÜŞ FERİDE NUR A Rare Adverse Effect of Anti-Tumor Necrosis Factor Alpha Therapy: Sarcoidosis. , 2017, ss.67 - 70.
AMA MENGİ G,GÖĞÜŞ F A Rare Adverse Effect of Anti-Tumor Necrosis Factor Alpha Therapy: Sarcoidosis. . 2017; 67 - 70.
Vancouver MENGİ G,GÖĞÜŞ F A Rare Adverse Effect of Anti-Tumor Necrosis Factor Alpha Therapy: Sarcoidosis. . 2017; 67 - 70.
IEEE MENGİ G,GÖĞÜŞ F "A Rare Adverse Effect of Anti-Tumor Necrosis Factor Alpha Therapy: Sarcoidosis." , ss.67 - 70, 2017.
ISNAD MENGİ, Gönen - GÖĞÜŞ, FERİDE NUR. "A Rare Adverse Effect of Anti-Tumor Necrosis Factor Alpha Therapy: Sarcoidosis". (2017), 67-70.
APA MENGİ G, GÖĞÜŞ F (2017). A Rare Adverse Effect of Anti-Tumor Necrosis Factor Alpha Therapy: Sarcoidosis. Archives of Rheumatology, 32(1), 67 - 70.
Chicago MENGİ Gönen,GÖĞÜŞ FERİDE NUR A Rare Adverse Effect of Anti-Tumor Necrosis Factor Alpha Therapy: Sarcoidosis. Archives of Rheumatology 32, no.1 (2017): 67 - 70.
MLA MENGİ Gönen,GÖĞÜŞ FERİDE NUR A Rare Adverse Effect of Anti-Tumor Necrosis Factor Alpha Therapy: Sarcoidosis. Archives of Rheumatology, vol.32, no.1, 2017, ss.67 - 70.
AMA MENGİ G,GÖĞÜŞ F A Rare Adverse Effect of Anti-Tumor Necrosis Factor Alpha Therapy: Sarcoidosis. Archives of Rheumatology. 2017; 32(1): 67 - 70.
Vancouver MENGİ G,GÖĞÜŞ F A Rare Adverse Effect of Anti-Tumor Necrosis Factor Alpha Therapy: Sarcoidosis. Archives of Rheumatology. 2017; 32(1): 67 - 70.
IEEE MENGİ G,GÖĞÜŞ F "A Rare Adverse Effect of Anti-Tumor Necrosis Factor Alpha Therapy: Sarcoidosis." Archives of Rheumatology, 32, ss.67 - 70, 2017.
ISNAD MENGİ, Gönen - GÖĞÜŞ, FERİDE NUR. "A Rare Adverse Effect of Anti-Tumor Necrosis Factor Alpha Therapy: Sarcoidosis". Archives of Rheumatology 32/1 (2017), 67-70.